Featured Products

  1. A Cell Therapy Manufacturing Platform Made To Automate Key Steps 6/13/2024

    The Sefia™ cell therapy manufacturing platform is made up of two digitally integrated and functionally closed systems that automate key manufacturing steps. 

  2. A Platform To Transform Cell Therapy Manufacturing 6/13/2024

    Explore this end-to-end cell therapy solution transforming cell therapy manufacturing and helping you deliver what’s next in CAR T manufacturing, from starting sample to final doses.

  3. A Comprehensive Upstream Platform For Gene Therapy Applications 5/6/2024

    Explore a variety of cell lines, high-performance cell culture media, and single-use bioreactors to suit your process needs for any cell type.

  4. Comprehensive Solution For Autologous Cell Therapy Manufacturing 3/25/2024

    Explore detailed information regarding a comprehensive solution for cell therapy manufacturing that consists of two hardware components, specialized application software, and single-use kits.

  5. An Inside Look At Cell Therapy Services And Support 3/25/2024

    “Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.

  6. Producer Cell Line To Elevate Your AAV Production To The Next Level 3/6/2024

    Discover a true producer cell line where Rep, Helper, Cap, and the gene of interest are stably integrated into the host cell's genome, requiring only a single induction step to initiate AAV production.

  7. A Stable Cell Line For Inducible AAV Production 3/6/2024

    Delivering on the promise of AAV-based gene therapies beyond rare diseases will require large quantities of high-quality AAV, produced in a robust manner.

  8. AAV Manufacturing Workflow 10/20/2023

    Explore scalable and flexible single-use solutions from design to delivery that can help you overcome challenges throughout adeno-associated virus (AAV) manufacturing workflow.

  9. Single-Use System For Clinical And Commercial Production Of LNPs 7/21/2023

    Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.

  10. Automated, Single-Use System For Clinical And Commercial LNP Production 7/21/2023

    The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.